Oncology & Cancer

New prostate cancer test improves risk assessment

(Medical Xpress)—A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk ...

Oncology & Cancer

New drugs, new ways to target androgens in prostate cancer therapy

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives ...

Diseases, Conditions, Syndromes

Surveillance biopsy timing not tied to reclassification

(HealthDay)—Timing of the first active surveillance biopsy is not associated with increased adverse reclassification of prostate cancer, according to a study published in the April issue of The Journal of Urology.

Oncology & Cancer

High-tech prostate scan may boost cancer detection

(HealthDay)—An innovative fusion of MRI and ultrasound might be a better way to detect and assess prostate cancer, while helping men avoid unnecessary biopsies, researchers say.

page 7 from 11